| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.066 | 0.4 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.4 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.15 | 0.4 |